BOK Financial’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-64
Closed -$82K 906
2018
Q4
$82K Sell
64
-565
-90% -$867K ﹤0.01% 860
2018
Q3
$1.19M Sell
629
-1,040
-62% -$2.15M 0.03% 468
2018
Q2
$3.39M Buy
1,669
+516
+45% +$1.18M 0.09% 264
2018
Q1
$2.55M Sell
1,153
-381
-25% -$969K 0.07% 306
2017
Q4
$3.54M Sell
1,534
-5
-0.3% -$10.2K 0.1% 245
2017
Q3
$2.74M Sell
1,539
-100
-6% -$140K 0.08% 270
2017
Q2
$2.23M Buy
1,639
+12
+0.7% +$14.5K 0.07% 290
2017
Q1
$1.92M Buy
1,627
+45
+3% +$45.9K 0.06% 326
2016
Q4
$1.26M Buy
1,582
+1,162
+277% +$923K 0.04% 414
2016
Q3
$369K Buy
+420
New +$304K 0.01% 711
2016
Q1
Sell
-1,177
Closed -$979K 845
2015
Q4
$979K Buy
+1,177
New +$1.18M 0.04% 438

Other funds holding BLUE

BOK Financial's BLUE Position: Q1 2019 in Review

BOK Financial sold out of bluebird bio (BLUE) in Q1 2019, closing a stake of 64 shares — an estimated $82K sold.

BOK Financial first reported a position in BLUE in Q4 2015 and held it in 11 quarters. The position peaked at $3.54M in Q4 2017. 288 funds tracked by Wall St. Rank hold BLUE as of Q1 2019.

  • BOK Financial reported no remaining bluebird bio position as of Q1 2019 after selling out during the quarter.
  • BOK Financial sold 64 bluebird bio shares in Q1 2019, an estimated $82K.
  • BOK Financial first reported a position in bluebird bio in Q4 2015 and held it in 11 quarters.
  • BOK Financial's bluebird bio position peaked at $3.54M in Q4 2017.
  • 288 funds tracked by Wall St. Rank held bluebird bio as of Q1 2019.

Based on BOK Financial's 13F filing for Q1 2019, filed 15 May 2019.